Effect of Stretching Exercises Versus Aerobic Exercises on Preeclampsia

NCT ID: NCT07255677

Last Updated: 2025-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-30

Study Completion Date

2026-01-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to compare between the effect of stretching exercises and aerobic exercises on preeclampsia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Preeclampsia increases maternal morbidity and mortality since the 1980s, Studies from the World Health Organization also showed an increased risk of hemorrhagic stroke with history of hypertension in pregnancy. In addition to this increased risk of thrombosis, there is also increased morbidity and mortality associated specifically with stroke in these women. PE lead to preterm delivery and increase neonatal morbidity such as Intrauterine Growth Restriction (IUGR), Risk of Fet al Demise/Stillbirth, and infants have a nine times greater incidence of respiratory distress syndrome than full-term neonate.

Medical treatments of preeclampsia . have a lot of side effects on mother and fetus. So, we are going to study more effective noninvasive therapy methods to prevent and decrease the risk of PE. In this randomized controlled study (RCT).

Several studies have explored the impact of exercise on the management and prevention of preeclampsia:

The Effect of Maternal Exercise Program on Fet al Growth in Pre-Eclampsia: A Prospective, Randomized Controlled Clinical Trial investigated the impact of a structured maternal exercise program on fet al growth in women diagnosed with preeclampsia. The findings suggested that regular, supervised exercise could positively influence fet al growth parameters in this cases. Impact of Exercise Training on Preeclampsia: Potential Preventive Mechanisms This review examined the potential mechanisms through which exercise training might reduce the risk of developing preeclampsia. The authors discussed how regular physical activity could improve endothelial function, reduce oxidative stress, and modulate immune responses, thereby potentially lowering preeclampsia risk. Aerobic Exercise Training in Formerly Preeclamptic Women: Effects on Venous Reserve In this study, they examined the effects of aerobic exercise training on venous reserves in 24 normotensive formerly preeclamptic women and 20 controls. Before and after 12-week aerobic exercise training, they demonstrate that 12 weeks of aerobic exercise training effectively improves venous reserve capacity in postpartum women. An umbrella review by Martínez highlighted that prenatal exercise can lead to systolic blood pressure (SBP) reductions of about 9.6 mmHg, alongside significant reductions in diastolic blood pressure (DBP) - with substantial evidence quality. In 2023 a meta-analysis of 14 RCTs (2010-2023) confirmed that prenatal physical activity reduces the risk of gestational hypertensive disorders by 56% and lowers SBP by 2.64 mmHg and DBP by 1.99 mmHg. More specifically, a meta-analysis focusing on aerobic and resistance training showed that while exercise didn't significantly change BP in low-risk pregnancies, in at-risk women it reduced SBP by 3.91 mmHg and DBP by 2.9 mmHg.

Another meta-analysis of 18 RCTs reported overall mean reductions of SBP by 3.19 mmHg and DBP by 2.14 mmHg in exercising pregnant women compared to controls.

Comparing studies like study done by Awad 2019 to find Effect of stretching exercises versus autogenic training on preeclampsia research published in the Journal of Advanced Pharmaceutical Technology \& Research compared the effects of stretching exercises and autogenic training on preeclamptic women. The study found that both interventions led to significant reductions in blood pressure and proteinuria levels, with stretching exercises showing a slightly more pronounced effect. This indicates that stretching can be an effective non-pharmacological approach to managing preeclampsia symptoms, another comparison of walking versus stretching exercises to reduce the incidence of preeclampsia: a randomized clinical trial a study conducted by the University of North Carolina at Chapel Hill found that pregnant women with a history of preeclampsia who engaged in regular stretching exercises experienced a lower incidence of the condition compared to those who participated in walking programs. Specifically, 5% of women in the stretching group developed preeclampsia, versus 14% in the walking group. The researchers hypothesized that stretching might increase levels of transferrin, a protein that combats oxidative stress, thereby offering protective benefits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preeclampsia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stretching exercises program + Antihypertensive drugs

It will consist of 30 women with mild preeclampsia. They will be treated with a stretching exercise program, conducted three times per week for six weeks, alongside antihypertensive drugs.

Group Type EXPERIMENTAL

Stretching exercises program

Intervention Type OTHER

Each woman in the first experimental group will follow a supervised stretching exercise program three times per week for six weeks. Sessions will begin with deep breathing warm-up, followed by stretching each target muscle for 10 seconds with 10 seconds relaxation for the first two weeks, 15 seconds stretching and relaxation in weeks three and four, and 20 seconds in weeks five and six. Each stretch will be repeated 10 times per session. After six weeks, women will be instructed to continue these exercises until delivery.

Antihypertensive drugs

Intervention Type DRUG

All women in both groups will be treated by antihypertensive drugs (labipress) for 6 weeks.

Aerobic exercises program + Antihypertensive drugs

It will consist of 30 women with mild preeclampsia. They will be treated with an aerobic exercise program, conducted three times per week for six weeks, alongside antihypertensive drugs.

Group Type EXPERIMENTAL

Aerobic exercises program

Intervention Type OTHER

The second experimental group will follow a supervised aerobic exercise program of mild to moderate intensity (40%-60% HRmax, calculated as 220 minus age). Heart rate will be monitored before and during exercise. The program, conducted three times per week for six weeks, will start with a 5-minute low-speed walking warm-up. In the first two weeks, this will be followed by 10 minutes on a treadmill (King Fitness Model 8000AC), 5 minutes relaxation, 10 minutes on a stationary bike (GRASP93026), and 5 minutes relaxation. In weeks three and four, treadmill and bike sessions will increase to 15 minutes each, with 10 minutes relaxation between. In weeks five and six, treadmill and bike time will increase to 20 minutes, with 15 minutes relaxation between. After six weeks, women will continue these exercises until delivery.

Antihypertensive drugs

Intervention Type DRUG

All women in both groups will be treated by antihypertensive drugs (labipress) for 6 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stretching exercises program

Each woman in the first experimental group will follow a supervised stretching exercise program three times per week for six weeks. Sessions will begin with deep breathing warm-up, followed by stretching each target muscle for 10 seconds with 10 seconds relaxation for the first two weeks, 15 seconds stretching and relaxation in weeks three and four, and 20 seconds in weeks five and six. Each stretch will be repeated 10 times per session. After six weeks, women will be instructed to continue these exercises until delivery.

Intervention Type OTHER

Aerobic exercises program

The second experimental group will follow a supervised aerobic exercise program of mild to moderate intensity (40%-60% HRmax, calculated as 220 minus age). Heart rate will be monitored before and during exercise. The program, conducted three times per week for six weeks, will start with a 5-minute low-speed walking warm-up. In the first two weeks, this will be followed by 10 minutes on a treadmill (King Fitness Model 8000AC), 5 minutes relaxation, 10 minutes on a stationary bike (GRASP93026), and 5 minutes relaxation. In weeks three and four, treadmill and bike sessions will increase to 15 minutes each, with 10 minutes relaxation between. In weeks five and six, treadmill and bike time will increase to 20 minutes, with 15 minutes relaxation between. After six weeks, women will continue these exercises until delivery.

Intervention Type OTHER

Antihypertensive drugs

All women in both groups will be treated by antihypertensive drugs (labipress) for 6 weeks.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

labipress

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Their ages ranged from 20-30 years old.
* Their body mass index (BMI) didn't exceed 35 Kg\\m2.
* All women primigravida.
* All women are complaining of mild preeclampsia.

Exclusion Criteria

* Chronic disease (diabetes mellitus, thyroid, hypertension, nephrotic).
* Vaginal bleeding.
* Placenta previa.
* Physical and psychological disorders.
Minimum Eligible Age

20 Years

Maximum Eligible Age

30 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mai Khaled Abdrabo Naeem

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed Ahmad Mohamed Awad, PhD

Role: STUDY_CHAIR

Professor, Cairo university

Mai Mohamed Ali, PhD

Role: STUDY_DIRECTOR

Assistant Professor, Cairo University

Amir Araby Gabre, PhD

Role: STUDY_DIRECTOR

Professor, Cairo university

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cairo University

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mai Khaled Abdrabo Naeem, B.Sc

Role: CONTACT

+20 102 176 6648

Mai Mohamed Ali, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mai Khaled Abdrabo Naeem, B.Sc

Role: primary

+20 102 176 6648

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/005974

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Physical Activity in Pregnancy
NCT03277807 COMPLETED